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Nosocomial and Community-Acquired Staphylococcus aureus Bacteremias from 
1980 to 1993: Impact of Intravascular Devices and Methicillin Resistance 
James P. Steinberg, Catherine C. Clark, 
and Betsy 0. Hackman 
From the Division of Infectious Diseases, Department of Medicine, 
Emory University School of Medicine, and the Infection Control 
Department, Crawford Long Hospital of Emory University, 
Atlanta, Georgia 
The rate of nosocomial bacteremia due to Staphylococcus aureus has increased over the past 
decade, but trends in community-acquired S. aureus bacteremia are less certain. This hospital-based 
observational study compares nosocomial and community-acquired S. aureus bacteremias during 
1980-1983 and 1990-1993. The rate of nosocomial S. aureus bacteremia increased from 0.75 to 
2.80 cases per 1,000 discharges, while the rate of community-acquired S. aureus bacteremia increased 
from 0.84 to 2.43 cases per 1,000 discharges. The number of nosocomial device-related bacteremias 
increased eightfold; 56% of S. aureus bacteremias were associated with devices during 1990-1993. 
Intravascular devices were associated with no community-acquired S. aureus bacteremias during 
1980-1983 but with 22% during 1990-1993. Methicillin-resistant S. aureus (MRSA) seldom caused 
bacteremia during 1980-1983. From 1990 to 1993, MRSA caused 32% and 18.5% of nosocomial 
and community-acquired S. aureus bacteremias, respectively. The rates of both community-acquired 
and nosocomial S. aureus bacteremias have increased significantly since 1980. In addition to their 
role in nosocomial infections, MRSA and intravascular device-related S. aureus bacteremias are 
emerging problems in the nonhospital setting. 
In the 1980s, gram-positive organisms, including Staphylo- 
coccus aureus, reemerged as the leading causes of nosocomial 
bacteremia [1, 2]. From 1980 to 1989, the National Nosocomial 
Infections Surveillance System (NNIS) of the Centers for Dis- 
ease Control and Prevention (CDC) reported increases in the 
rates of primary bacteremia due to S. aureus of 122% to 283% 
[1]. During the late 1980s, S. aureus caused 16% of nosocomial 
bacteremias reported to the NNIS, second only to coagulase- 
negative staphylococci [3]. An increase in the rate of S. aureus 
bacteremias also has been observed abroad. In Denmark, the 
annual incidence rate of S. aureus bacteremia increased from 
2.7 cases per 100,000 population in 1960 to 19.2 cases per 
100,000 population in 1990, with nosocomial bacteremias ac- 
counting for most of this increase [4]. 
See the editorial by Darouiche and Musher 
on pages 260-1. 
A larger population of immunocompromised individuals and 
increased use of intravascular devices are among the factors 
causing this resurgence of staphylococcal bacteremias. In addi- 
tion, the emergence of methicillin-resistant S. aureus (MRSA) 
contributes to the upward trend in S. aureus infections. Changes 
in community-acquired S. aureus bacteremia re less well char- 
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acterized. The objectives of this study are to describe trends 
in nosocomial and community-acquired S. aureus bacteremias 
since 1980 and to examine risk factors for S. aureus bacteremia 
including the impact of intravascular devices. 
Methods 
Crawford Long Hospital of Emory University is a 500-bed 
acute care hospital in downtown Atlanta. Community-based 
physicians and full-time university faculty utilize the facility, 
which serves as both a community hospital and a referral center. 
All bloodstream infections were identified by the infection 
control department as part of routine surveillance. For this 
study, we compared bloodstream infections due to S. aureus 
during 1980-1983 with those during 1990-1993. Clinical in- 
formation, including the presence of underlying diseases and 
source of bacteremia, was obtained by chart review. Nosoco- 
mial bacteremia was defined by a bloodstream isolate obtained 
-48 hours after hospital admission, while community-acquired 
bacteremia was defined by a bloodstream isolate obtained 
within 48 hours of hospital admission. However, blood isolates 
obtained within 48 hours of readmission were classified as 
nosocomial if the infection was determined by the infection 
control practitioner to be incubating at the time of a recent 
(<30 days) hospital discharge. 
Blood isolates of S. aureus were considered to be contami- 
nants if only one blood culture set yielded the organisms, if 
the clinicians judged the organisms to be contaminants, and 
if antibiotic therapy directed against the organisms was not 
administered. 
Intravascular device-related S. aureus bacteremia was de- 
fined as bacteremia unrelated to infection at an extravascular 
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Figure 1. Rates of nosocomial and community-acquired bacter- 
emias due to methicillin-resistant Staphylococcus aureus (MRSA), 
methicillin-susceptible S. aureus (MSSA), and other bacteria (exclud- 
ing mycobacteria) during two study periods. 
site with semiquantitative culture of a catheter tip yielding > 15 
colonies or with infection at a local catheter site that was due 
to the same organism. When the catheter was not removed or 
the tip was not cultured, the infection was considered to be 
device-related if the infection control practitioner, the hospital 
epidemiologist, or the involved clinicians determined a device 
to be the likely source. 
During the 1980-1983 study period, the hospital microbiol- 
ogy laboratory used the BACTEC 460 radiometric system (Bec- 
ton Dickinson, Sparks, MD); for each set of blood cultures, a 
7.5- to 10-mL blood sample was inoculated into aerobic, anaer- 
obic, and hypertonic media. During the 1990-1993 study pe- 
riod, the BACTEC 660 nonradiometric system (Becton Dickin- 
son) was used; a blood sample of 20 mL was inoculated into 
aerobic and anaerobic vials. 
During both study periods, the hospital's policy called for 
replacement of peripheral intravenous catheters after 72 hours. 
There was no similar standard governing the duration of the 
placement of central venous catheters. From 1980-1983, there 
was limited use of central venous catheters outside of the inten- 
sive care units, and implanted ports and tunneled cuffed cathe- 
ters were either not commercially available or not used. 
The Mantel-Haenszel X2 test was used to determine statisti- 
cal significance. 
Results 
The rate of bacteremia doubled during the second 4-year 
period, with the rate of nosocomial bacteremia increasing from 
4.59 to 9.44 cases per 1,000 discharges and the rate of commu- 
nity-acquired bacteremia increasing from 6.2 to 13.46 per 1,000 
discharges (figure 1). The rates of nosocomial and community- 
acquired S. aureus bacteremias also increased from 0.75 to 
2.80 cases per 1,000 discharges and from 0.84 to 2.43 cases 
per 1,000 discharges, respectively. 
Table 1 shows the numbers of S. aureus and other bacter- 
emias for the study periods. The proportion of nosocomial 
bacteremia caused by S. aureus increased from 16.3% to 29.6% 
(P < .001), and the proportion of community-acquired bacter- 
emia caused by S. aureus increased from 13.5% to 18.1% 
(P < .05). The annual average number of blood cultures per- 
formed also doubled from 7,758 to 15,725, while the annual 
number of hospital discharges decreased slightly from 22,117 
to 20,540 over the same periods. Two S. aureus isolates (1.4%) 
recovered from blood cultures were considered contaminants 
during the first period compared with 14 (3.1%) during the 
second period. 
Sources of Bacteremia and Underlying Diseases 
The sources for all S. aureus bacteremias during the study 
periods are shown in table 2. The number of intravascular 
device-associated nosocomial S. aureus bacteremias increased 
eightfold from 16 (25% of total) during 1980-1983 to 128 
(56% of total) during 1990-1993. This increase in the number 
of device-associated bacteremias accounts for 70% of the in- 
crease in the number of nosocomial S. aureus bloodstream 
infections. Fifty-two percent of the device-associated bacter- 
emias from the 1990-1993 period were confirmed by cultures 
of catheter tips or specimens from device sites that yielded S. 
aureus. 
No single source accounted for the increase in the number 
of community-acquired S. aureus bacteremias (table 2). Intra- 
vascular devices, not documented as a source of community- 
acquired bacteremia in the 1980-1983 period, were associated 
with 43 community-acquired bacteremias (22%) in the 1990- 
1993 period. These infections resulted primarily from long- 
term indwelling catheters (see next section). Skin and soft- 
tissue infections caused 44 community-acquired bacteremias 
(22%) in the 1990-1993 period. Of these 44 infections, 16 
(nine due to MRSA) were from infected decubitus ulcers in 
nursing home patients, and 11 were from lower extremity infec- 
tions in patients with diabetes or vascular insufficiency. Bacter- 
emias related to hemodialysis shunts and fistulas were common 
in both study periods. 
Two patients with community-acquired bacteremia in the 
1980-1983 period and four patients in the 1990-1993 period 
were intravenous drug users. Comparing 1990-1993 with 
1980-1983, nursing home residence (16% vs. 4%, respec- 
tively), AIDS (10% vs. 0, respectively), and sickle cell anemia 
(8% vs. 0, respectively) were significantly (P < .05) more 
common, whereas diabetes (27% vs. 22%, respectively), renal 
failure (28% vs. 35%, respectively), and cancer (9% vs. 16%, 
respectively) were not. The mean age of patients with commu- 
nity-acquired bacteremia was 55 years in the 1980-1983 period 
and 57.6 years in the 1990-1993 period. Although nursing 
home residence was more common in the 1990-1993 period, 
a greater percentage of patients were 65 years of age or older 
in the earlier period (45% vs. 39%, respectively). Sixty-five 
percent of patients with community-acquired S. aureus bacter- 
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Table 1. Numbers of nosocomial and community-acquired bacteremias during 1980-1983 and 
1990-1993. 
No. of bacteremias due to indicated pathogen 
Type of bacteremia, Staphylococcus aureus Other gram-positive Gram-negative 
study period (total) MRSA organisms organisms Total 
Nosocomial 
1980-1983 16.5 0.25 25.5 65 101.5 
1990-1993 57.5 18 84 67 194 
Community-acquired 
1980-1983 18.5 0.25 33 88 137 
1990-1993 50 9 93 142.5 276.5 
NOTE. Data represent average numbers of bacteremias per year during the 4-year study period. MRSA = 
methicillin-resistant S. aureus. 
emia during the second study period were hospitalized within 
1 year before the bacteremia, and 52% were hospitalized within 
90 days of the bacteremia. 
Types of Intravascular Devices 
The types of intravascular devices associated with S. aureus 
bloodstream infections are listed in table 3. From 1990 to 1993, 
central venous catheters and peripheral intravascular catheters 
were associated with 31% and 18%, respectively, of the noso- 
comial device-related infections. These bacteremias occurred in 
patients with a wide variety of underlying medical and surgical 
Table 2. Sources of Staphylococcus aureus bacteremia during the 
two study periods. 
No. of bacteremias due to MRSA/ 
total no. due to S. aureus 
Source 1980-1983 1990-1993 
Nosocomial 
Intravascular devices 1/16 30/128* 
Unknown 0/23 12/54 
Surgical wound infection 0/10 15/19 
Skin/decubitus ulcers 0/3 6/9 
Respiratory tract 0/5 6/11 
Other 0/8 4/9 
Total 1/65 73/230 
Community-acquired 
Intravascular devices 0/0 8/43* 
Unknownt 0/27 7/52 
Dialysis shunt or fistula 1/18 5/28 
Skin/decubitus ulcers 0/7 13/44' 
Bone/joint 0/4 0/11 
Intravenous drug use 0/2 0/4 
Respiratory tract 0/10* 0/4 
Other 0/6 4/14 
Total 1/74 37/200 
* Significant difference, P < .01. 
t Includes cases where multiple possible sources were identified. 
Significant difference, P < .05. 
problems. Implanted ports were the source of 25% of the noso- 
comial bacteremias; 18 (56%) of the port-related infections 
occurred in patients with sickle cell disease, and 12 (38%) 
occurred in oncology patients. The 18 bacteremias in patients 
with sickle cell disease occurred in 12 patients. Six patients 
each had two bacteremias associated with implanted ports; the 
same device was implicated as the source in three of these six 
patients. 
Sources of community-acquired device-related bacteremias 
during 1990-1993 included implanted ports (49%), hemodialy- 
sis catheters (33%), tunneled cuffed catheters (9%), and periph- 
eral intravenous catheters (5%). The 43 bacteremias occurred 
in 39 patients. Underlying diseases in these patients included 
chronic renal failure (36%), AIDS (23%), sickle cell anemia 
(21%), and cancer (8%). 
MRSA Bacteremia 
Only one nosocomial MRSA bacteremia occurred in the 
1980-1983 period. During the 1990-1993 period, MRSA 
caused 73 nosocomial S. aureus bacteremias (32%). Sources 
of these bacteremias are listed in table 2. 
Thirty-seven community-acquired MRSA bacteremias oc- 
curred from 1990 to 1993, whereas only one occurred a decade 
earlier. These 37 bacteremias occurred in 35 patients, all of 
whom had ongoing contact with health care settings. The pa- 
tient had been hospitalized at our institution within the previous 
year in 24 (65%) of the cases; in 19 cases (51%), the patient 
had been hospitalized within the previous 90 days. Fourteen 
(40%) of the patients with community-acquired MRSA bacter- 
emia resided in nursing homes. Forty-five percent (14 of 31) 
of S. aureus bacteremias occurring in nursing home residents 
were caused by MRSA. 
Underlying diseases in patients with community-acquired 
MRSA bacteremia included diabetes (29%), chronic renal fail- 
ure (23%), cancer (14%), AIDS (9%), and sickle cell anemia 
(3%). Nursing home residence, but not any of these underlying 
diseases, was associated with a significantly higher risk of 
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Table 3. Types of intravascular devices associated with Staphylococcus aureus bacteremia during two 
study periods. 
No. of S. aureus infections associated with indicated catheter 
Type of infection, Peripheral Central 
study period intravenous venous* Tunneledt p Ports? Hemodialysis Otherl 
Nosocomial 
1980-1983 5 7 0 0 0 4 
1990-1993 23 40 8 32 3 22 
Community-acquired 
1980-1983 0 0 0 0 0 0 
1990-1993 2 1 4 21 14 1 
* Includes single-, double-, and triple-lumen catheters. 
t Tunneled cuffed catheters, primarily Hickman catheters. 
* Not in use during 1980-1983. 
? Implanted ports. 
II Includes arterial catheters, Swan-Ganz catheters, umbilical catheters, and femoral vein catheters. 
MRSA infection (P < .001). The mean age of patients with 
community-acquired MRSA bacteremia was 67.7 years; 58% 
were 65 years of age or older. 
Discussion 
This study shows a significant increase in the number of 
community-acquired as well as nosocomial S. aureus bacter- 
emias at our institution from 1980-1983 to 1990-1993. The 
increase in the number of nosocomial S. aureus bacteremias is 
consistent with data generated by NNIS and other investigators 
[1, 2, 4, 5]. However, there are little comparable data on trends 
in community-acquired S. aureus bacteremia. Intravascular de- 
vices are the major source of nosocomial S. aureus bacteremia 
and are emerging as important sources of community-acquired 
bacteremia. Similarly, MRSA has emerged as a cause of bacter- 
emia in patients outside the hospital setting. 
Intravascular devices, implicated in no community-acquired 
bacteremias during the first study period, were associated with 
22% of community-acquired S. aureus bacteremias from 1990 
to 1993. We believe that this increase likely reflects the shifting 
of acute medical care to the outpatient setting and the increasing 
use of long-term devices in patients with chronic disorders, 
such as AIDS, cancer, and sickle cell disease. Although outpa- 
tient infusion therapy has been associated with a low rate of 
infectious complications [6], given current economic pressures, 
this low rate is likely to apply to an increasing population. In 
addition, the low reported rate of infections may not apply to 
all populations. Thus, a further increase in the total number 
of cases of community-acquired device-related infections may 
occur. 
MRSA was responsible for 32% of nosocomial S. aureus 
bacteremias during the 1990-1993 period, a proportion consis- 
tent with NNIS data for hospitals of comparable size [7]. 
MRSA also caused 18.5% of community-acquired S. aureus 
bacteremias from 1990 to 1993. Most of these infections oc- 
curred in patients who had been hospitalized recently or were 
nursing home residents, and all patients with community- 
acquired MRSA bacteremia had regular contact with health 
care settings. 
Our definition of nosocomial infection was adapted from 
definitions of the CDC that were designed for the NNIS hospi- 
tals [8]; all other infections were termed community-acquired. 
For patients with chronic medical illnesses who may require 
periodic hospitalizations, home health care, and, possibly, out- 
patient parenteral therapy, the term community-acquired is mis- 
leading. These patients are at greater risk for serious infections, 
including those caused by antibiotic-resistant microorganisms 
such as MRSA, than are those without prior contact with health 
care facilities. For example, approximately two of three patients 
admitted to our hospital with community-acquired bacteremia 
due to S. aureus (methicillin-susceptible S. aureus or MRSA) 
had been hospitalized within the previous year. 
The term nosohusial has been suggested to describe infec- 
tions occurring in patients who receive care at home [6]. 
Whether this new term finds widespread acceptance, the dis- 
tinction between patients requiring frequent contact with health 
care settings and those whose infections are truly community- 
acquired is valid. The increase in the number of patients receiv- 
ing care at home emphasizes the need to develop methods for 
studying infections occurring in this setting. Although useful 
information can be obtained from hospital-based surveillance, 
an accurate determination of infection rates occurring in non- 
hospital settings should utilize the population at risk as the 
denominator. In addition, the use of multiple commercial clini- 
cal laboratories for performing culture and sensitivity testing 
further complicates attempts to determine infection rates in the 
nonhospital setting. Thus, further home care-based studies are 
warranted. 
These data show a significant increase in the number of 
intravascular device-associated bacteremias since 1980. Be- 
cause of the design of this study, we were unable to measure 
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device utilization or establish infection rates associated with 
various types of devices. However, the increased use of intra- 
vascular devices, particularly central venous catheters, has been 
implicated in the increased rates of septicemia from 1979 to 
1987 that were recorded by the National Hospital Discharge 
Survey [9]. Fifty-six percent of nosocomial bacteremias in the 
second study period were device-related, a figure consistent 
with those of other published series [10]. Fifty-two percent of 
the nosocomial device-associated infections during the second 
study period were confirmed by cultures of catheter tips or 
specimens from device sites that yielded S. aureus. A more 
rigorous definition of device-associated infection, such as re- 
quiring cultures of catheter tips or specimens from device sites, 
could have led to a significant underestimation of the impact 
of devices. We believe that it is more likely that some of the 
bacteremias termed as unknown were device-related and that 
our calculation of device-associated infections is conservative. 
A surprising finding in our study was the high number of 
nosocomial and community-acquired port-related bacteremias. 
Implanted ports have been associated with a low incidence of 
infection (range, 0.01-0.04 bloodstream infections per 100 
device-days [11, 12]). Our data reflect, in part, a large popula- 
tion of patients with diseases such as sickle cell anemia and 
AIDS and a high utilization of implanted ports in these patients. 
In addition, suboptimal care of the devices and patient use of 
ports for injection of illicit drugs were suspected in a few 
instances. Although we were unable to determine rates of port- 
related bacteremia, our experience raises concern that the re- 
ported incidence of port-related infections may not apply to all 
settings. Notwithstanding the inferences about rates of port- 
related infection, these data demonstrate how the use of im- 
planted ports can change the epidemiology of bloodstream in- 
fections. 
The overall increase in the rates of bacteremia may be con- 
founded by changes in blood culturing methodology and an 
increase in the number of blood cultures performed. During 
the 1990-1993 study period, the standard blood specimen for 
a set of blood cultures was 20 mL, twice that obtained in the 
1980-1983 period. A recent controlled trial demonstrated that 
increasing the volume of blood inoculated into a culture vial 
from 2.7 mL to 8.7 mL increased the yield of gram-positive 
pathogens by 19% [13]. The number of blood cultures per- 
formed per year doubled from the first to the second study 
period. This pattern of increased utilization of blood cultures 
during the 1980s has been reported by other researchers and 
has been attributed to the presence of a sicker patient popula- 
tion [14]. 
The annual number of bacteremias also doubled in the sec- 
ond study period, resulting in a stable rate of blood culture 
positivity. This finding suggests that the methodological 
changes were not the major cause of the increased rates of 
bacteremia during 1990-1993. It is also unlikely that these 
factors accounted for the disproportionate increases in the num- 
bers of S. aureus and device-related bacteremias. 
In summary, these data show parallel increases in rates of 
nosocomial and community-acquired S. aureus bacteremias 
since 1980. Device-related infection, the leading source of nos- 
ocomial S. aureus bacteremia, is emerging as an important 
source of community-acquired bacteremia in our hospital. Sim- 
ilarly, MRSA bacteremia, once confined to the nosocomial 
setting, is an increasing problem in the nonhospital setting. The 
shifting of care, including parenteral therapy, to the outpatient 
setting likely accounts for some of these observations. 
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